Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Central Nervous System Neoplasms | 2 | 2022 | 895 | 0.480 |
Why?
|
Antibodies, Antinuclear | 1 | 2015 | 326 | 0.470 |
Why?
|
Myelodysplastic Syndromes | 1 | 2018 | 1352 | 0.330 |
Why?
|
Liver Diseases | 1 | 2015 | 1253 | 0.290 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2016 | 2104 | 0.280 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 2736 | 0.250 |
Why?
|
Immunotherapy | 1 | 2018 | 4437 | 0.220 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2019 | 4033 | 0.220 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2018 | 3524 | 0.220 |
Why?
|
Sirolimus | 3 | 2018 | 1565 | 0.190 |
Why?
|
Skin Neoplasms | 1 | 2019 | 5691 | 0.170 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2022 | 640 | 0.160 |
Why?
|
Electron Transport Chain Complex Proteins | 1 | 2016 | 38 | 0.140 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2016 | 69 | 0.140 |
Why?
|
Ethmoid Sinus | 1 | 2016 | 58 | 0.140 |
Why?
|
Isotope Labeling | 1 | 2018 | 405 | 0.140 |
Why?
|
Mitochondria, Liver | 1 | 2016 | 187 | 0.140 |
Why?
|
Caloric Restriction | 1 | 2018 | 302 | 0.130 |
Why?
|
Methotrexate | 1 | 2022 | 1726 | 0.130 |
Why?
|
Vaccines | 1 | 2023 | 823 | 0.120 |
Why?
|
rab4 GTP-Binding Proteins | 1 | 2014 | 7 | 0.120 |
Why?
|
Free Radical Scavengers | 1 | 2015 | 216 | 0.120 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2016 | 234 | 0.120 |
Why?
|
Acetylcysteine | 1 | 2015 | 271 | 0.120 |
Why?
|
Azathioprine | 1 | 2015 | 354 | 0.120 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 418 | 0.120 |
Why?
|
Mycophenolic Acid | 1 | 2015 | 343 | 0.110 |
Why?
|
Ubiquitin | 1 | 2018 | 851 | 0.110 |
Why?
|
Alanine Transaminase | 1 | 2015 | 593 | 0.110 |
Why?
|
Phagosomes | 1 | 2014 | 193 | 0.110 |
Why?
|
Cyclosporine | 1 | 2015 | 788 | 0.110 |
Why?
|
Oxygen Consumption | 2 | 2016 | 1869 | 0.110 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2016 | 332 | 0.110 |
Why?
|
Complement System Proteins | 1 | 2015 | 796 | 0.100 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1377 | 0.100 |
Why?
|
Monoacylglycerol Lipases | 1 | 2012 | 48 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1832 | 0.100 |
Why?
|
Cancer Vaccines | 1 | 2018 | 1023 | 0.100 |
Why?
|
Phosphatidylinositols | 1 | 2012 | 291 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2018 | 2110 | 0.090 |
Why?
|
Mitochondrial Membranes | 1 | 2012 | 174 | 0.090 |
Why?
|
Prednisone | 1 | 2015 | 1574 | 0.090 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1120 | 0.090 |
Why?
|
Sex Distribution | 1 | 2015 | 2298 | 0.090 |
Why?
|
Immunotherapy, Adoptive | 1 | 2018 | 1271 | 0.090 |
Why?
|
Mitochondria | 2 | 2014 | 3513 | 0.090 |
Why?
|
Aspirin | 1 | 2021 | 3283 | 0.080 |
Why?
|
Microtubule-Associated Proteins | 1 | 2014 | 1083 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 3070 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2727 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2021 | 5316 | 0.070 |
Why?
|
Muscle Proteins | 1 | 2012 | 1158 | 0.070 |
Why?
|
Autophagy | 1 | 2014 | 1296 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2016 | 4152 | 0.070 |
Why?
|
Anticoagulants | 1 | 2021 | 4599 | 0.070 |
Why?
|
Mitochondrial Proteins | 1 | 2012 | 993 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2016 | 3082 | 0.070 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11036 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9239 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2012 | 2504 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 7908 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2012 | 2938 | 0.050 |
Why?
|
Injections, Spinal | 1 | 2022 | 303 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 3706 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2015 | 13980 | 0.040 |
Why?
|
Aging | 1 | 2018 | 8655 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2012 | 8430 | 0.040 |
Why?
|
Prevalence | 1 | 2015 | 15211 | 0.040 |
Why?
|
Microfluidics | 1 | 2023 | 662 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15526 | 0.040 |
Why?
|
Transaldolase | 1 | 2016 | 9 | 0.040 |
Why?
|
beta 2-Glycoprotein I | 1 | 2016 | 28 | 0.040 |
Why?
|
Half-Life | 1 | 2018 | 660 | 0.040 |
Why?
|
Antibodies, Anticardiolipin | 1 | 2016 | 62 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2012 | 5170 | 0.040 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2016 | 158 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5752 | 0.040 |
Why?
|
Leucine | 1 | 2018 | 559 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2022 | 63042 | 0.030 |
Why?
|
Dynamins | 1 | 2016 | 152 | 0.030 |
Why?
|
Humans | 10 | 2023 | 743811 | 0.030 |
Why?
|
Blepharoptosis | 1 | 2016 | 143 | 0.030 |
Why?
|
Ocular Motility Disorders | 1 | 2016 | 135 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2022 | 77410 | 0.030 |
Why?
|
Male | 5 | 2022 | 349776 | 0.030 |
Why?
|
Aged | 3 | 2022 | 163178 | 0.030 |
Why?
|
Intracellular Membranes | 1 | 2014 | 391 | 0.030 |
Why?
|
Oculomotor Muscles | 1 | 2016 | 370 | 0.030 |
Why?
|
Macrolides | 1 | 2014 | 201 | 0.030 |
Why?
|
Cohort Studies | 1 | 2015 | 40545 | 0.030 |
Why?
|
Phosphatidic Acids | 1 | 2012 | 49 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6773 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2018 | 1962 | 0.030 |
Why?
|
Animals | 3 | 2018 | 168660 | 0.030 |
Why?
|
Antibody Formation | 1 | 2016 | 1402 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 35409 | 0.020 |
Why?
|
Phosphatidylinositol Phosphates | 1 | 2012 | 209 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4561 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2014 | 13809 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2203 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2018 | 2123 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2014 | 1545 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 18107 | 0.020 |
Why?
|
Middle Aged | 3 | 2022 | 213241 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3874 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 21824 | 0.020 |
Why?
|
Adult | 3 | 2022 | 213889 | 0.020 |
Why?
|
Female | 5 | 2022 | 380020 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5179 | 0.020 |
Why?
|
Headache | 1 | 2016 | 1224 | 0.020 |
Why?
|
Proteome | 1 | 2018 | 1794 | 0.020 |
Why?
|
Protein Transport | 1 | 2014 | 1988 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1656 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2012 | 2029 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2012 | 16674 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2012 | 3847 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2022 | 57744 | 0.020 |
Why?
|
RNA Interference | 1 | 2012 | 2890 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 21675 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20948 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3504 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14563 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9377 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7793 | 0.010 |
Why?
|
Phosphorylation | 1 | 2012 | 8436 | 0.010 |
Why?
|
Mice | 2 | 2018 | 81154 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15993 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4463 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18027 | 0.010 |
Why?
|
Young Adult | 1 | 2022 | 56392 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23398 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13691 | 0.010 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_